On May 15, 2023, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and a Registrant to address issues occurring from 2018 to the end of May 2023 related to narcotic diversion. During this time period, the Registrant diverted narcotics for off-duty use. They entered their workplace while off work in order to withdraw narcotics under patient names, used the security pass of another person when their own was deactivated, and misrepresented their health in order to get a peer to insert intravenous access. The Registrant was diagnosed with, and admitted to, a disability with a causal relationship to the practice issues via an independent medical report and has agreed to comply with treatment recommendations. They have voluntarily agreed to terms equivalent to limits and conditions on their practice, including:
A suspension of nursing registration for four weeks.
Not to return to work until abstinent and medically cleared.
Disclosure of treatment recommendations to relevant employer representative(s).
Limits impacting access to and handling of narcotics, with concurrent medical monitoring, to support the stable return to fitness to practice for a minimum of two years.
Limits on being sole nurse on duty, working overtime and working nights for one year.
The Agreement will remain in place for a minimum of four years.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the terms will protect the public.